Skip to main content

Cavernous Angioma clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Biomarkers of CASH

    Sorry, not currently recruiting here

    The project aims to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with cavernous angiomas, a critical clinical challenge in a disease affecting more than a million Americans. We further examine whether blood biomarkers can replace or enhance the accuracy of advanced imaging in association with lesional bleeding. The project tests a novel integrational approach of biomarker development in a mechanistically defined cerebrovascular disease, with a clinically relevant context of use.

    San Francisco, California and other locations

Last updated: